It’s always exciting when small-cap companies make it as a Yahoo Finance trending ticker. Today, December 19th, the PPCB stock made it. Propanc Biopharma (OTCQB:PPCB) has a current market cap of $11.488 million.
On Wednesday, PPCB stock shot up more than 30%, likely caused by investor optimism over yesterday’s announcement.
PPCB Stock Killin’ the Game
Yesterday, December 18th, Propanc Biopharma, which is based in Melbourne, Australia, announced the selection of its communications agency of record. After debating, LaVoieHealthScience (LHS) was the winner.
The choice doesn’t come as too much of a surprise, though. Considering Propanc Biopharma is a development-stage healthcare company that focuses on developing new as well as proprietary treatments for cancer patients, and LHS focuses on furthering science and health innovations and has a significant track record, the match makes sense. Not to mention Propanc Biopharma is looking to transition into human clinical trials, which LHS can help with.
Speaking on the news, CEO of LHS Donna L. LaVoie said the LHS team is “delighted” to be working with Propanc Biopharma. Together they will bring “novel therapies into the clinical trials stage,” with the goal of providing “new hope for patients suffering from metastatic cancer.”
PPCB Stock Price
Working together is a smart move for both companies, and the market seems to agree. According to Yahoo Finance, as of 1:54 PM, PPCB stock is trading at $0.047, which puts the stock up 34.29%. Earlier in the trading day, PPCB stock was up 40%.
It will be interesting to see if the stock can move any higher before the closing bell rings or if it will have a similar trading day tomorrow, December 20th.
As we move into the new year, this will be a duo worth keeping an eye on it. The health sector is always working on improving, and Propanc Biopharma and LaVoieHealthScience could very well be the reason behind certain improvements.
What do you think about PPCB stock?
Featured Image: Depositphotos/mariocigic